Send to

Choose Destination
J Innate Immun. 2018;10(5-6):455-464. doi: 10.1159/000491439. Epub 2018 Aug 27.

Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.

Author information

Department of Medical Microbiology, Utrecht University Medical Center, Utrecht, The Netherlands.
Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Department of Medical Microbiology, Utrecht University Medical Center, Utrecht, The


Complement is a complex protein network of plasma, and an integral part of the innate immune system. Complement activation results in the rapid clearance of bacteria by immune cells, and direct bacterial killing via large pore-forming complexes. Here we review important recent discoveries in the complement field, focusing on interactions relevant for the defense against bacteria. Understanding the molecular interplay between complement and bacteria is of great importance for future therapies for infectious and inflammatory diseases. Antibodies that support complement-dependent bacterial killing are of interest for the development of alternative therapies to treat infections with antibiotic-resistant bacteria. Furthermore, a variety of novel therapeutic complement inhibitors have been developed to prevent unwanted complement activation in autoimmune inflammatory diseases. A better understanding of how such inhibitors may increase the risk of bacterial infections is essential if such therapies are to be successful.


Antibiotic resistance; Antibody therapy; Bacteria; Complement; Eculizumab; Infections; Inflammatory diseases; Membrane attack complex; Neisseria

Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center